Interleukin-1 receptor antagonist prevents murine bronchopulmonary dysplasia induced by perinatal inflammation and hyperoxia
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Interleukin-1 receptor antagonist prevents murine bronchopulmonary dysplasia induced by perinatal inflammation and hyperoxia
Authors
Keywords
-
Journal
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Volume 110, Issue 35, Pages 14384-14389
Publisher
Proceedings of the National Academy of Sciences
Online
2013-08-15
DOI
10.1073/pnas.1306859110
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Sustained response and prevention of damage progression in patients with neonatal-onset multisystem inflammatory disease treated with anakinra: A cohort study to determine three- and five-year outcomes
- (2012) Cailin H. Sibley et al. ARTHRITIS AND RHEUMATISM
- Role of bone marrow-derived mesenchymal stem cells in the prevention of hyperoxia-induced lung injury in newborn mice
- (2012) Xiaoying Zhang et al. CELL BIOLOGY INTERNATIONAL
- Transepithelial migration of neutrophils into the lung requires TREM-1
- (2012) Julia Klesney-Tait et al. JOURNAL OF CLINICAL INVESTIGATION
- Treating inflammation by blocking interleukin-1 in a broad spectrum of diseases
- (2012) Charles A. Dinarello et al. NATURE REVIEWS DRUG DISCOVERY
- Association between bronchopulmonary dysplasia and MBL2 and IL1-RN polymorphisms
- (2012) Bilin Cetinkaya Cakmak et al. PEDIATRICS INTERNATIONAL
- Connective Tissue Growth Factor Antibody Therapy Attenuates Hyperoxia-Induced Lung Injury in Neonatal Rats
- (2011) Deepthi Alapati et al. AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY
- Interleukin-1 in the pathogenesis and treatment of inflammatory diseases
- (2011) C. A. Dinarello BLOOD
- Long-term response after 6-year treatment with anakinra and onset of focal bone erosion in neonatal-onset multisystem inflammatory disease (NOMID/CINCA)
- (2011) Donato Rigante et al. RHEUMATOLOGY INTERNATIONAL
- Chorioamnionitis stimulates angiogenesis in saccular stage fetal lungs via CC chemokines
- (2010) J. Davin Miller et al. AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY
- The new bronchopulmonary dysplasia
- (2010) Alan H Jobe CURRENT OPINION IN PEDIATRICS
- Deficits in lung alveolarization and function after systemic maternal inflammation and neonatal hyperoxia exposure
- (2010) Markus Velten et al. JOURNAL OF APPLIED PHYSIOLOGY
- IL-37 is a fundamental inhibitor of innate immunity
- (2010) Marcel F Nold et al. NATURE IMMUNOLOGY
- The use of viral load as a surrogate marker in predicting disease progression for patients with early invasive cervical cancer with integrated human papillomavirus type 16
- (2009) Surasak Wanram et al. AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY
- IL-1 Mediates Pulmonary and Systemic Inflammatory Responses to Chorioamnionitis Induced by Lipopolysaccharide
- (2009) Suhas G. Kallapur et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Low Birth Weight and Respiratory Disease in Adulthood
- (2009) Eric C. Walter et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Bronchopulmonary dysplasia: Definitions and long-term respiratory outcome
- (2009) Eugenio Baraldi et al. EARLY HUMAN DEVELOPMENT
- Bronchopulmonary Dysplasia in a Rat Model Induced by Intra-amniotic Inflammation and Postnatal Hyperoxia: Morphometric Aspects
- (2009) Chang Won Choi et al. PEDIATRIC RESEARCH
- Cytokines Associated With Bronchopulmonary Dysplasia or Death in Extremely Low Birth Weight Infants
- (2009) N. Ambalavanan et al. PEDIATRICS
- Bronchopulmonary dysplasia and inflammatory biomarkers in the premature neonate
- (2008) C L Bose et al. Archives of Disease in Childhood-Fetal and Neonatal Edition
- MIP-3α and MIP-1α rapidly mobilize dendritic cell precursors into the peripheral blood
- (2008) Shan He et al. JOURNAL OF LEUKOCYTE BIOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started